Clinical study on vyanga w.s.r to melasma
Phase 2
- Conditions
- Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/11/060373
- Lead Sponsor
- Sri Jayachamarajendra Institute of Indian Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects having classical symptoms of Vyanga will be selected randomly irrespective of gender for the study.
Exclusion Criteria
Pregnant women, nursing mothers.
Subjects suffering from other pigmentation disorders like vitiligo, Pityriasis Alba etc
Subjects who have used any cosmetic depigmenting agent within 2 weeks prior to inclusion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreases the Hyper Pigmentation on Face.Timepoint: 4 Weeks.
- Secondary Outcome Measures
Name Time Method Decrease of Circular Patches on Face.Timepoint: 2 weeks..